Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals Limitedverified

SHUKRAPHAR.BO

Price:

$59.06

Market Cap:

$25.86B

Shukra Pharmaceuticals Ltd. manufactures and markets pharmaceutical products in both domestic and international markets. Its portfolio includes antibiotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic. The company was founded on March 4, 1993 and is headquartered in Ahmedabad, India.

Industry

Medical - Pharmaceuticals

IPO Date

1998-12-30

Stock Exchange

BSE

Ticker

SHUKRAPHAR.BO

The Enterprise Value as of December 2025 (TTM) for Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) is 25.90B

According to Shukra Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 25.90B. This represents a change of 158.95% compared to the average of 10.00B of the last 4 quarters.

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) Historical Enterprise Value (quarterly & annually)

How has SHUKRAPHAR.BO Enterprise Value performed in the past?

The mean historical Enterprise Value of Shukra Pharmaceuticals Limited over the last ten years is 80.12B. The current 25.90B Enterprise Value has changed 3.13% with respect to the historical average. Over the past ten years (40 quarters), SHUKRAPHAR.BO's Enterprise Value was at its highest in in the March 2016 quarter at 779.51B. The Enterprise Value was at its lowest in in the December 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

80.12B

Median

2.01B

Minimum

37.16M

Maximum

779.51B

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Shukra Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 23.65%

Maximum Annual Enterprise Value = 779.51B

Minimum Annual Increase = -99.87%

Minimum Annual Enterprise Value = 37.16M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20259.24B169.11%
20243.43B8.46%
20233.17B224.52%
2022975.86M23.39%
2021790.87M-73.70%
20203.01B4.52%
201965.15M75.34%
201837.16M-96.35%
20171.02B-99.87%
2016779.51B23.65%

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) Average Enterprise Value

How has SHUKRAPHAR.BO Enterprise Value performed in the past?

The current Enterprise Value of Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

5.28B

5-year avg

3.52B

10-year avg

80.12B

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) Enterprise Value vs. Peers

How is SHUKRAPHAR.BO’s Enterprise Value compared to its peers?

Shukra Pharmaceuticals Limited’s Enterprise Value is greater than Suraksha Diagnostic Limited (15.37B), greater than Suraksha Diagnostic Limited (15.37B), greater than TTK Healthcare Limited (9.01B), greater than Megasoft Limited (12.69B), greater than Bliss GVS Pharma Limited (16.85B), greater than Bliss GVS Pharma Limited (16.85B), greater than Tarsons Products Limited (12.25B), greater than Tarsons Products Limited (12.25B), greater than Syncom Formulations (India) Limited (13.58B), greater than Syncom Formulations (India) Limited (13.58B),

Build a custom stock screener for Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shukra Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shukra Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Shukra Pharmaceuticals Limited's Enterprise Value?

What is the highest Enterprise Value for Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)?

What is the 3-year average Enterprise Value for Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)?

What is the 5-year average Enterprise Value for Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)?

How does the current Enterprise Value for Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) compare to its historical average?